Sharon Elad1,2, Yehuda Zadik3,4. 1. Division of Oral Medicine and Hospital General Dentistry, Eastman Institute for Oral Health, University of Rochester Medical Center, 625 Elmwood Ave, Rochester, NY, 14620, USA. 2. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA. 3. Department of Oral Medicine, Oral and Maxillofacial Institute, Medical Corps, Israel Defense Forces, Tel Hashomer, Israel. yehudaz@hadassah.org.il. 4. Department of Oral Medicine, Sedation and Maxillofacial Imaging, Hebrew University-Hadassah School of Dental Medicine, P.O.Box 12272, Jerusalem, 9112102, Israel. yehudaz@hadassah.org.il.
Abstract
PURPOSE: Oral mucositis is a major complication of anticancer therapy yet the literature focuses on immediate (acute) mucosal changes and hardly describes the chronic form. We aim to report the clinical manifestations of chronic mucositis. METHODS: A retrospective chart review of oral mucositis referrals was performed. Inclusion/exclusion criteria defined the patients that were considered to have chronic mucositis. RESULTS: Four female patients treated for tongue/lower lip squamous cell carcinoma were included. Extensive painful oral mucositis lesions developed in all patients during the course of radiotherapy, with ulcers remaining for 5-24 months after completion of therapy. We describe two presentations, namely the persistent form (long-lasting ulcers continuing from acute ulcers) and the recurrent form (new discrete ulcers appearing on atrophic mucosa following the completion of radiotherapy). CONCLUSIONS: The long-term oral complications of radiotherapy to the head and neck may include chronic atrophic, erythematous, and/or ulcerated lesions. A diagnosis of chronic oral mucositis should be considered when the lesions are observed at least 3 months after radiotherapy, and other possible etiologies have been excluded. The influence of age and comorbidities (primarily diabetes mellitus) on chronic mucositis, the significance to patient's quality of life, and the management of chronic mucositis are important subjects for future research.
PURPOSE:Oral mucositis is a major complication of anticancer therapy yet the literature focuses on immediate (acute) mucosal changes and hardly describes the chronic form. We aim to report the clinical manifestations of chronic mucositis. METHODS: A retrospective chart review of oral mucositis referrals was performed. Inclusion/exclusion criteria defined the patients that were considered to have chronic mucositis. RESULTS: Four female patients treated for tongue/lower lip squamous cell carcinoma were included. Extensive painful oral mucositis lesions developed in all patients during the course of radiotherapy, with ulcers remaining for 5-24 months after completion of therapy. We describe two presentations, namely the persistent form (long-lasting ulcers continuing from acute ulcers) and the recurrent form (new discrete ulcers appearing on atrophic mucosa following the completion of radiotherapy). CONCLUSIONS: The long-term oral complications of radiotherapy to the head and neck may include chronic atrophic, erythematous, and/or ulcerated lesions. A diagnosis of chronic oral mucositis should be considered when the lesions are observed at least 3 months after radiotherapy, and other possible etiologies have been excluded. The influence of age and comorbidities (primarily diabetes mellitus) on chronic mucositis, the significance to patient's quality of life, and the management of chronic mucositis are important subjects for future research.
Authors: Guido B van den Broek; Alfons J M Balm; Michiel W M van den Brekel; Michael Hauptmann; Jan H Schornagel; Coen R N Rasch Journal: Radiother Oncol Date: 2006-10-19 Impact factor: 6.280
Authors: Barbara Roa Pauloski; Alfred W Rademaker; Jerilyn A Logemann; Donna Lundy; Michelle Bernstein; Carrie McBreen; Daphne Santa; Angela Campanelli; Lisa Kelchner; Bernice Klaben; Muveddet Discekici-Harris Journal: Head Neck Date: 2010-08-24 Impact factor: 3.147
Authors: Deborah P Saunders; Joel B Epstein; Sharon Elad; Justin Allemano; Paolo Bossi; Marianne D van de Wetering; Nikhil G Rao; Carin Potting; Karis K Cheng; Annette Freidank; Michael T Brennan; Joanne Bowen; Kristopher Dennis; Rajesh V Lalla Journal: Support Care Cancer Date: 2013-07-06 Impact factor: 3.603
Authors: Cesar Migliorati; Ian Hewson; Rajesh V Lalla; Heliton Spindola Antunes; Cherry L Estilo; Brian Hodgson; Nilza Nelly Fontana Lopes; Mark M Schubert; Joanne Bowen; Sharon Elad Journal: Support Care Cancer Date: 2012-09-22 Impact factor: 3.603
Authors: Nam P Nguyen; Paul Vos; Vincent Vinh-Hung; Thomas L Borok; Suresh Dutta; Ulf Karlsson; Howard Lee; Tomas Martinez; Beng-Hoey Jo; Ly M Nguyen; Nga Nguyen; Sabah Sallah Journal: Anticancer Res Date: 2009-11 Impact factor: 2.480
Authors: Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad Journal: Cancer Date: 2014-02-25 Impact factor: 6.860
Authors: Caroline de Bataille; Vincent Sibaud; Angélique Prioul; Anne Laprie; Emmanuelle Vigarios Journal: Support Care Cancer Date: 2017-10-09 Impact factor: 3.603
Authors: L Hu; Y Wang; A P Cotrim; Z Zhu; R Gao; C Zheng; C M Goldsmith; L Jin; C Zhang; J B Mitchell; B J Baum; S Wang Journal: Oral Dis Date: 2017-04-27 Impact factor: 3.511
Authors: R V Lalla; N Treister; T Sollecito; B Schmidt; L L Patton; K Mohammadi; J S Hodges; M T Brennan Journal: Oral Dis Date: 2017-08-03 Impact factor: 3.511
Authors: Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun Journal: Front Oncol Date: 2022-08-30 Impact factor: 5.738
Authors: Mette Marcussen; Mads Sønderkær; Julie Støve Bødker; Maria Andersen; Søren Nielsen; Charles Vesteghem; Ilse Christiansen; Olav Jonas Bergmann; Martin Bøgsted; Karen Dybkær; Mogens Vyberg; Hans Erik Johnsen Journal: PLoS One Date: 2018-01-16 Impact factor: 3.240